Atherothrombosis and high-risk plaque: Part I: Evolving concepts

Journal of the American College of Cardiology

Volumn 46, Issue 6, 2005, Pages 937-954

  Fuster, Valentin ^a   Moreno, Pedro R ^a   Fayad, Zahi A ^a   Corti, Roberto ^b   Badimon, Juan J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROTEOGLYCAN; TOLL LIKE RECEPTOR;

ACUTE HEART INFARCTION; APOPTOSIS; ARTERY CALCIFICATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; ENDOTHELIUM LESION; EROSION; FLOW KINETICS; HEALING; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LIPID TRANSPORT; MACROPHAGE; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RUPTURE; SUDDEN DEATH; SYMPTOM; THROMBOGENESIS; THROMBOGENICITY; THROMBOSIS; UNSTABLE ANGINA PECTORIS; VASA VASORUM;

ATHEROSCLEROSIS; DISEASE PROGRESSION; HUMANS; RISK FACTORS; RUPTURE, SPONTANEOUS; THROMBOSIS;

EID: 24944513945     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.03.074     Document Type: Review

References (207)

1. V. Fuster, L. Badimon, J.J. Badimon, J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes (1) N Engl J Med 326 1992 242 250
2. V. Fuster, L. Badimon, J.J. Badimon, J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes (2) N Engl J Med 326 1992 310 318
3. R. Ross, J.A. Glomset The pathogenesis of atherosclerosis (first of two parts) N Engl J Med 295 1976 369 377
4. R. Ross, J.A. Glomset The pathogenesis of atherosclerosis (second of two parts) N Engl J Med 295 1976 420 425
5. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
6. K.J. Williams, I. Tabas The response-to-retention hypothesis of early atherogenesis Arterioscler Thromb Vasc Biol 15 1995 551 561
7. E. Falk, P.K. Shah, V. Fuster Coronary plaque disruption Circulation 92 1995 657 671
8. P. Libby Molecular bases of the acute coronary syndromes Circulation 91 1995 2844 2850
9. P. Libby Atherosclerosis the new view Sci Am 286 2002 46 55
10. M.J. Davies Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995 Circulation 94 1996 2013 2020
11. P.R. Moreno, E. Falk, I.F. Palacios, J.B. Newell, V. Fuster, J.T. Fallon Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture Circulation 90 1994 775 778
12. H.C. Stary Composition and classification of human atherosclerotic lesions Virchows Arch 421 1992 277 290
13. H.C. Stary, A.B. Chandler, S. Glagov A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation 89 1994 2462 2478
14. H.C. Stary, A.B. Chandler, R.E. Dinsmore A definition of advanced types of atherosclerotic lesions and a histologic classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Circulation 92 1995 1355 1374
15. S.M. Schwartz, D. deBlois, E.R. O'Brien The intima. Soil for atherosclerosis and restenosis Circ Res 77 1995 445 465
16. A. Daugherty, E. Pure, D. Delfel-Butteiger The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice J Clin Invest 100 1997 1575 1580
17. A. Daugherty, D.L. Rateri T lymphocytes in atherosclerosis the yin-yang of Th1 and Th2 influence on lesion formation Circ Res 90 2002 1039 1040
18. P. Libby, P.M. Ridker, A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
19. P.R. Moreno, K.R. Purushothaman, V. Fuster, W.N. O'Connor Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta implications for plaque vulnerability Circulation 105 2002 2504 2511
20. P.R. Moreno, K.R. Purushothaman, V. Fuster, D. Echeverri, H. Trucszczynska, W.N. O'Connor Tunica media and plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta implications for plaque vulnerability Circulation 110 2004 2032 2038
21. F.D. Kolodgie, H.K. Gold, A.P. Burke Intraplaque hemorrhage and progression of coronary atheroma N Engl J Med 349 2003 2316 2325
22. J.A. Ware Too many vessels? Not enough? The wrong kind? The VEGF debate continues Nat Med 7 2001 403 404
23. J.K. Williams, D.D. Heistad [The vasa vasorum of the arteries] J Mal Vasc 21 Suppl C 1996 266 269
24. A.P. Burke, A. Farb, G.T. Malcom, Y.H. Liang, J. Smialek, R. Virmani Coronary risk factors and plaque morphology in men with coronary disease who died suddenly N Engl J Med 336 1997 1276 1282
25. A. Farb, A.P. Burke, A.L. Tang Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death Circulation 93 1996 1354 1363
26. J.A. Schaar, J.E. Muller, E. Falk Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece Eur Heart J 25 2004 1077 1082
27. H.C. Stary Natural history and histologic classification of atherosclerotic lesions an update Arterioscler Thromb Vasc Biol 20 2000 1177 1178
28. J.G. Canto, M.G. Shlipak, W.J. Rogers Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain JAMA 283 2000 3223 3229
29. S.E. Sheifer, T.A. Manolio, B.J. Gersh Unrecognized myocardial infarction Ann Intern Med 135 2001 801 811
30. T. Pohl, C. Seiler, M. Billinger Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease J Am Coll Cardiol 38 2001 1872 1878
31. G.S. Werner, M. Ferrari, S. Betge, O. Gastmann, B.M. Richartz, H.R. Figulla Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion Circulation 104 2001 2784 2790
32. R. Virmani, F.D. Kolodgie, A.P. Burke, A. Farb, S.M. Schwartz Lessons from sudden coronary death a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275
33. P.O. Bonetti, L.O. Lerman, A. Lerman Endothelial dysfunction a marker of atherosclerotic risk Arterioscler Thromb Vasc Biol 23 2003 168 175
34. L.J. Ignarro Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation beta-blocker Blood Press Suppl 1 2004 2 16
35. L.J. Ignarro, C. Napoli Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis Curr Atheroscler Rep 6 2004 281 287
36. B. Voetsch, R.C. Jin, J. Loscalzo Nitric oxide insufficiency and atherothrombosis Histochem Cell Biol 122 2004 353 367
37. J. Ravensbergen, J.W. Ravensbergen, J.K. Krijger, B. Hillen, H.W. Hoogstraten Localizing role of hemodynamics in atherosclerosis in several human vertebrobasilar junction geometries Arterioscler Thromb Vasc Biol 18 1998 708 716
38. R.M. Nerem Vascular fluid mechanics, the arterial wall, and atherosclerosis J Biomech Eng 114 1992 274 282
39. M.A. Gimbrone Jr., T. Nagel, J.N. Topper Biomechanical activation an emerging paradigm in endothelial adhesion biology J Clin Invest 99 1997 1809 1813
40. O. Traub, T. Ishida, M. Ishida, J.C. Tupper, B.C. Berk Shear stress-mediated extracellular signal-regulated kinase activation is regulated by sodium in endothelial cells. Potential role for a voltage-dependent sodium channel J Biol Chem 274 1999 20144 20150
41. C. Kunsch, R.M. Medford Oxidative stress as a regulator of gene expression in the vasculature Circ Res 85 1999 753 766
42. H. Cai, D.G. Harrison Endothelial dysfunction in cardiovascular diseases the role of oxidant stress Circ Res 87 2000 840 844
43. A.M. Malek, S.L. Alper, S. Izumo Hemodynamic shear stress and its role in atherosclerosis JAMA 282 1999 2035 2042
44. R. De Caterina, T. Bourcier, U. Laufs Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-κB Arterioscler Thromb Vasc Biol 21 2001 227 232
45. M. Haim, D. Tanne, V. Boyko Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) study J Am Coll Cardiol 39 2002 1133 1138
46. Z.M. Dong, S.M. Chapman, A.A. Brown, P.S. Frenette, R.O. Hynes, D.D. Wagner The combined role of P-and E-selectins in atherosclerosis J Clin Invest 102 1998 145 152
47. I. Malik, J. Danesh, P. Whincup Soluble adhesion molecules and prediction of coronary heart disease a prospective study and meta-analysis Lancet 358 2001 971 976
48. I.M. van der Meer, M.P. de Maat, M.L. Bots Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis the Rotterdam Study Arterioscler Thromb Vasc Biol 22 2002 838 842
49. D.P.S. Steinberg, T.E. Carew, J.C. Khoo, J.L. Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
50. M.F. Khalil, W.D. Wagner, I.J. Goldberg Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis Arterioscler Thromb Vasc Biol 24 2004 2211 2218
51. Y. Zhang, I. Zanotti, M.P. Reilly, J.M. Glick, G.H. Rothblat, D.J. Rader Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo Circulation 108 2003 661 663
52. P.J. Barter, S. Nicholls, K.A. Rye, G.M. Anantharamaiah, M. Navab, A.M. Fogelman Antiinflammatory properties of HDL Circ Res 95 2004 764 772
53. P. Barter HDL a recipe for longevity Atheroscler Suppl 5 2004 25 31
54. P.K. Shah, S. Kaul, J. Nilsson, B. Cercek Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins an idea whose time for testing is coming, part I Circulation 104 2001 2376 2383
55. P.K. Shah, S. Kaul, J. Nilsson, B. Cercek Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins an idea whose time for testing is coming, part II Circulation 104 2001 2498 2502
56. J.J. Badimon, L. Badimon, A. Galvez, R. Dische, V. Fuster High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits Lab Invest 60 1989 455 461
57. J.J. Badimon, L. Badimon, V. Fuster Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit J Clin Invest 85 1990 1234 1241
58. S. Ameli, A. Hultgardh-Nilsson, B. Cercek Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits Circulation 90 1994 1935 1941
59. P.K. Shah, J. Nilsson, S. Kaul Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice Circulation 97 1998 780 785
60. P.K. Shah, J. Yano, O. Reyes High-dose recombinant apolipoprotein A-I(Milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice potential implications for acute plaque stabilization Circulation 103 2001 3047 3050
61. S.E. Nissen, T. Tsunoda, E.M. Tuzcu Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes a randomized controlled trial JAMA 290 2003 2292 2300
62. B.G. Brown, X.Q. Zhao, A. Chait Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease N Engl J Med 345 2001 1583 1592
63. M.C. Cheung, X.Q. Zhao, A. Chait, J.J. Albers, B.G. Brown Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL Arterioscler Thromb Vasc Biol 21 2001 1320 1326
64. G.K. Hansson, P. Libby, U. Schonbeck, Z.Q. Yan Innate and adaptive immunity in the pathogenesis of atherosclerosis Circ Res 91 2002 281 291
65. C.J. Binder, M.K. Chang, P.X. Shaw Innate and acquired immunity in atherogenesis Nat Med 8 2002 1218 1226
66. S. Gordon Pattern recognition receptors doubling up for the innate immune response Cell 111 2002 927 930
67. H.O. Andersen, P. Holm, S. Stender, B.F. Hansen, B.G. Nordestgaard Dose-dependent suppression of transplant arteriosclerosis in aorta-allografted, cholesterol-clamped rabbits. Suppression not eliminated by the cholesterol-raising effect of cyclosporine Arterioscler Thromb Vasc Biol 17 1997 2515 2523
68. D. Steinberg, J.L. Witztum Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105 2002 2107 2111
69. G.K. Hansson Immune mechanisms in atherosclerosis Arterioscler Thromb Vasc Biol 21 2001 1876 1890
70. M.E. Rosenfeld Leukocyte recruitment into developing atherosclerotic lesions the complex interaction between multiple molecules keeps getting more complex Arterioscler Thromb Vasc Biol 22 2002 361 363
71. Y. Okamura, M. Watari, E.S. Jerud The extra domain A of fibronectin activates Toll-like receptor 4 J Biol Chem 276 2001 10229 10233
72. M.F. Tsan, B. Gao Cytokine function of heat shock proteins Am J Physiol Cell Physiol 286 2004 C739 C744
73. M. Triantafilou, K. Triantafilou Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide Biochem Soc Trans 32 2004 636 639
74. A. Vink, A.H. Schoneveld, J.J. van der Meer In vivo evidence for a role of Toll-like receptor 4 in the development of intimal lesions Circulation 106 2002 1985 1990
75. G. Pasterkamp, J.K. Van Keulen, D.P. De Kleijn Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease Eur J Clin Invest 34 2004 328 334
76. S.C. Hollestelle, M.R. De Vries, J.K. Van Keulen Toll-like receptor 4 is involved in outward arterial remodeling Circulation 109 2004 393 398
77. J. Nilsson, G.K. Hansson, P.K. Shah Immunomodulation of atherosclerosis. Implications for vaccine development Arterioscler Thromb Vasc Biol 25 2005 1 11
78. L.A. Fitzpatrick, A. Severson, W.D. Edwards, R.T. Ingram Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis J Clin Invest 94 1994 1597 1604
79. E.R. O'Brien, M.R. Garvin, D.K. Stewart Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques Arterioscler Thromb 14 1994 1648 1656
80. T. Ikeda, T. Shirasawa, Y. Esaki, S. Yoshiki, K. Hirokawa Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta J Clin Invest 92 1993 2814 2820
81. D.A. Towler, M. Bidder, T. Latifi, T. Coleman, C.F. Semenkovich Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice J Biol Chem 273 1998 30427 30434
82. L. Liaw, D.M. Lombardi, M.M. Almeida, S.M. Schwartz, D. deBlois, C.M. Giachelli Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation Arterioscler Thromb Vasc Biol 17 1997 188 193
83. L. Liaw, M. Almeida, C.E. Hart, S.M. Schwartz, C.M. Giachelli Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro Circ Res 74 1994 214 224
84. M. Takemoto, K. Yokote, M. Yamazaki Enhanced expression of osteopontin by high glucose. Involvement of osteopontin in diabetic macroangiopathy Ann N Y Acad Sci 902 2000 357 363
85. M. Takemoto, K. Yokote, M. Nishimura Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis Arterioscler Thromb Vasc Biol 20 2000 624 628
86. S. Glagov, E. Weisenberg, C.K. Zarins, R. Stankunavicius, G.J. Kolettis Compensatory enlargement of human atherosclerotic coronary arteries N Engl J Med 316 1987 1371 1375
87. M.R. Ward, G. Pasterkamp, A.C. Yeung, C. Borst Arterial remodeling. Mechanisms and clinical implications Circulation 102 2000 1186 1191
88. F. Tronc, Z. Mallat, S. Lehoux, M. Wassef, B. Esposito, A. Tedgui Role of matrix metalloproteinases in blood flow-induced arterial enlargement interaction with NO Arterioscler Thromb Vasc Biol 20 2000 E120 E126
89. A.P. Burke, F.D. Kolodgie, A. Farb, D. Weber, R. Virmani Morphological predictors of arterial remodeling in coronary atherosclerosis Circulation 105 2002 297 303
90. P.J. Polverini, P.S. Cotran, M.A. Gimbrone Jr., E.R. Unanue Activated macrophages induce vascular proliferation Nature 269 1977 804 806
91. W.S. Lee, M.K. Jain, B.M. Arkonac Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines Circ Res 82 1998 845 851
92. J. Herrmann, L.O. Lerman, M. Rodriguez-Porcel Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia Cardiovasc Res 51 2001 762 766
93. H. Wolinsky, S. Glagov Nature of species differences in the medial distribution of aortic vasa vasorum in mammals Circ Res 20 1967 409 421
94. A.C. Barger, R. Beeuwkes 3rd, L.L. Lainey, K.J. Silverman Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis N Engl J Med 310 1984 175 177
95. D.D. Heistad, M.L. Marcus Role of vasa vasorum in nourishment of the aorta Blood Vessels 16 1979 225 238
96. J.K. Williams, M.L. Armstrong, D.D. Heistad Vasa vasorum in atherosclerotic coronary arteries responses to vasoactive stimuli and regression of atherosclerosis Circ Res 62 1988 515 523
97. S.G. Barker, A. Talbert, S. Cottam, P.A. Baskerville, J.F. Martin Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig Arterioscler Thromb 13 1993 70 77
98. S.G. Barker, L.C. Tilling, G.C. Miller The adventitia and atherogenesis removal initiates intimal proliferation in the rabbit which regresses on generation of a 'neoadventitia ' Atherosclerosis 105 1994 131 144
99. G.R. De Meyer, D.J. Van Put, M.M. Kockx Possible mechanisms of collar-induced intimal thickening Arterioscler Thromb Vasc Biol 17 1997 1924 1930
100. K.S. Moulton, E. Heller, M.A. Konerding, E. Flynn, W. Palinski, J. Folkman Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice Circulation 99 1999 1726 1732
101. K.S. Moulton, K. Vakili, D. Zurakowski Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis Proc Natl Acad Sci U S A 100 2003 4736 4741
102. H.M. Kwon, G. Sangiorgi, E.L. Ritman Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia J Clin Invest 101 1998 1551 1556
103. R.S. Scotland, P.J. Vallance, A. Ahluwalia Endogenous factors involved in regulation of tone of arterial vasa vasorum implications for conduit vessel physiology Cardiovasc Res 46 2000 403 411
104. M. Kumamoto, Y. Nakashima, K. Sueishi Intimal neovascularization in human coronary atherosclerosis its origin and pathophysiological significance Hum Pathol 26 1995 450 456
105. M. Fleiner, M. Kummer, M. Mirlacher Arterial neovascularization and inflammation in vulnerable patients early and late signs of symptomatic atherosclerosis Circulation 110 2004 2843 2850
106. K.R. Purushothaman, D. Echeverri, V. Fuster, W. O'Connor, P.R. Moreno Neovascularization, inflammation and intra-plaque hemorrhage are increased in advanced human atherosclerosis from patients with diabetes mellitus (abstr) Circulation 108 2003 459
107. K.R. Purushothaman, W.N. O'Connor, D. Echeverri, C. Amadi, J.J. Badimon, V. Fuster, P.R. Moreno Ruptured diabetic atherosclerotic plaques have more inflammation and neovascularization than ruptured plaques from patients without diabetes (abstr) J Am Coll Cardiol 43 Suppl A 2004 496A
108. K.R. Purushothaman, W.N. O'Connor, D. Echeverri, C. Amadi, S.K. Sharma, V. Fuster, P.R. Moreno Atherosclerotic plaque inflammation is associated with increased intimo-medial neovascularization (abstr) J Am Coll Cardiol 43 Suppl A 2004 477A
109. P.R. Moreno, K.R. Purushothaman, W.N. O'Connor, A. Kini, M. Sirol, S.K. Sharma, V. Fuster Microvessel sprouting, red blood cell extravasation, and peri-vascular inflammation is increased in plaques from patients with diabetes mellitus (abstr) J Am Coll Cardiol 45 Suppl A 2005 430A
110. K.R. Purushothaman, P.R. Moreno, W.N. O'Connor, A.S. Kini, S.K. Sharma, V. Fuster Histological evidence for atherosclerotic neovascularization as a pathway for macrophage infiltration in diabetes mellitus (abstr) J Am Coll Cardiol 45 Suppl A 2005 439A
111. P.R. Moreno, K.R. Purushothaman, V. Fuster Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta implications for plaque vulnerability Circulation 110 2004 2032 2038
112. P.R. Moreno, K.R. Purushothaman, W.N. O'Connor, A.S. Kini, M. Sirol, S.K. Sharma, V. Fuster Increased inflammation and neovascularization in diabetic atherosclerosis is no longer present in fibrocalcific plaques a marker of stabilization? (abstr) J Am Coll Cardiol 45 Suppl A 2005 402A
113. R. Corti, Z.A. Fayad, V. Fuster Effects of lipid-lowering by simvastatin on human atherosclerotic lesions a longitudinal study by high-resolution, noninvasive magnetic resonance imaging Circulation 104 2001 249 252
114. M.J. Davies, P.D. Richardson, N. Woolf, D.R. Katz, J. Mann Risk of thrombosis in human atherosclerotic plaques role of extracellular lipid, macrophage, and smooth muscle cell content Br Heart J 69 1993 377 381
115. M. Kaartinen, A. Penttila, P.T. Kovanen Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture Circulation 90 1994 1669 1678
116. P.K. Shah, E. Falk, J.J. Badimon Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture Circulation 92 1995 1565 1569
117. P.K. Shah, Z.S. Galis Matrix metalloproteinase hypothesis of plaque rupture players keep piling up but questions remain Circulation 104 2001 1878 1880
118. G.K. Sukhova, U. Schonbeck, E. Rabkin Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques Circulation 99 1999 2503 2509
119. Z.S. Galis, J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis the good, the bad, and the ugly Circ Res 90 2002 251 262
120. M. Zureik, L. Robert, D. Courbon, P.J. Touboul, L. Bizbiz, P. Ducimetiere Serum elastase activity, serum elastase inhibitors, and occurrence of carotid atherosclerotic plaques the Etude sur le Vieillissement Arteriel (EVA) study Circulation 105 2002 2638 2645
121. M.L. Lindsey, J. Gannon, M. Aikawa Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction Circulation 105 2002 753 758
122. S. Abou-Raya, A. Naim, S. Marzouk Cardiac matrix remodeling in congestive heart failure the role of matrix metalloproteinases Clin Invest Med 27 2004 93 100
123. V. Polyakova, S. Hein, S. Kostin, T. Ziegelhoeffer, J. Schaper Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression J Am Coll Cardiol 44 2004 1609 1618
124. B.H. Shah, K.J. Catt Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy Trends Endocrinol Metab 15 2004 241 243
125. D.A. Young, S. Gavrilov, C.J. Pennington Expression of metalloproteinases and inhibitors in the differentiation of P19CL6 cells into cardiac myocytes Biochem Biophys Res Commun 322 2004 759 765
126. E. Rabkin-Aikawa, M. Farber, M. Aikawa, F.J. Schoen Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves J Heart Valve Dis 13 2004 841 847
127. K. Skalen, M. Gustafsson, E.K. Rydberg Subendothelial retention of atherogenic lipoproteins in early atherosclerosis Nature 417 2002 750 754
128. G. Camejo Hydrolytic enzymes released from resident macrophages and located in the intima extracellular matrix as agents that modify retained apolipoprotein B lipoproteins Arterioscler Thromb Vasc Biol 23 2003 1312 1313
129. J.K. Hakala, R. Oksjoki, P. Laine Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions Arterioscler Thromb Vasc Biol 23 2003 1430 1436
130. P.N. Seshiah, D.J. Kereiakes, S.S. Vasudevan Activated monocytes induce smooth muscle cell death role of macrophage colony-stimulating factor and cell contact Circulation 105 2002 174 180
131. Z. Mallat, B. Hugel, J. Ohan, G. Leseche, J.M. Freyssinet, A. Tedgui Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques a role for apoptosis in plaque thrombogenicity Circulation 99 1999 348 353
132. R. Hutter, C. Valdiviezo, B.V. Sauter Caspase-3 and tissue factor expression in lipid-rich plaque macrophages evidence for apoptosis as link between inflammation and atherothrombosis Circulation 109 2004 2001 2008
133. R. Hutter, J.J. Badimon, B.V. Sauter, J.T. Fallon, V. Fuster Arterial injury in ApoII wild type mice. Evidence for macrophage apoptosis as a mechanism regulating tissue-factor expression and plaque growth (abstr) J Am Coll Cardiol 39 Suppl A 2002 257A
134. Z. Mallat, A. Tedgui Current perspective on the role of apoptosis in atherothrombotic disease Circ Res 88 2001 998 1003
135. V. Fuster, L. Badimon, J.J. Badimon, J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes. Parts 1 and 2 N Engl J Med 326 1992 242 250 and 310-8
136. P. Theroux, V. Fuster Acute coronary syndromes unstable angina and non-Q-wave myocardial infarction Circulation 97 1998 1195 1206
137. V. Fuster Mechanisms leading to myocardial infarction insights from studies of vascular biology Circulation 90 1994 2126 2146
138. V. Toschi, R. Gallo, M. Lettino Tissue factor modulates the thrombogenicity of human atherosclerotic plaques Circulation 95 1997 594 599
139. A. Fernandez-Ortiz, J.J. Badimon, E. Falk Characterization of the relative thrombogenicity of atherosclerotic plaque components implications for consequences of plaque rupture J Am Coll Cardiol 23 1994 1562 1569
140. J.D. Marmur, S.V. Thiruvikraman, B.S. Fyfe Identification of active tissue factor in human coronary atheroma Circulation 94 1996 1226 1232
141. U. Rauch, J.I. Osende, V. Fuster, J.J. Badimon, Z. Fayad, J.H. Chesebro Thrombus formation on atherosclerotic plaques pathogenesis and clinical consequences Ann Intern Med 134 2001 224 238
142. U. Rauch, D. Bonderman, B. Bohrmann Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor Blood 96 2000 170 175
143. B.J. Meyer, J.J. Badimon, A. Mailhac Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy Circulation 90 1994 2432 2438
144. B.J. Meyer, J.J. Badimon, J.H. Chesebro, J.T. Fallon, V. Fuster, L. Badimon Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin comparison with heparin and aspirin Circulation 97 1998 681 685
145. Y. Nemerson Tissue factor and hemostasis Blood 71 1988 1 8
146. D.W. Banner, A. D'Arcy, C. Chene The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor Nature 380 1996 41 46
147. P.R. Moreno, V.H. Bernardi, J. Lopez-Cuellar Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes Circulation 94 1996 3090 3097
148. R. Hutter, B.V. Sauter, J.T. Fallon, V. Fuster, J.J. Badimon Macrophages and vascular stellate cells in human carotid plaques are prone to apoptosis and tissue factor expression (abstr) J Am Coll Cardiol 38 Suppl A 2001 288A
149. J.J. Badimon, M. Lettino, V. Toschi Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions Circulation 99 1999 1780 1787
150. M. Roque, E.D. Reis, V. Fuster Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty J Am Coll Cardiol 36 2000 2303 2310
151. P.K. Shah Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis an epiphenomenon or potential culprit in re-thrombosis? Circulation 105 2002 270 271
152. I. Ott, V. Malcouvier, A. Schomig, F.J. Neumann Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction Circulation 105 2002 279 281
153. H. Kato Regulation of functions of vascular wall cells by tissue factor pathway inhibitor basic and clinical aspects Arterioscler Thromb Vasc Biol 22 2002 539 548
154. L. Badimon, J.J. Badimon Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model J Clin Invest 84 1989 1134 1144
155. M. Frojmovic, G. Nash, S.L. Diamond Definitions in biorheology: cell aggregation and cell adhesion in flow. Recommendation of the Scientific Subcommittee on Biorheology of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis Thromb Haemost 87 2002 771
156. J.T. Willerson, P. Golino, J. Eidt, W.B. Campbell, L.M. Buja Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications Circulation 80 1989 198 205
157. A. Maseri, A. L'Abbate, G. Baroldi Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina N Engl J Med 299 1978 1271 1277
158. I.J. Kullo, W.D. Edwards, R.S. Schwartz Vulnerable plaque pathobiology and clinical implications Ann Intern Med 129 1998 1050 1060
159. I.J. Kullo, G.T. Gau, A.J. Tajik Novel risk factors for atherosclerosis Mayo Clin Proc 75 2000 369 380
160. V. Salomaa, V. Rasi, S. Kulathinal Hemostatic factors as predictors of coronary events and total mortality the FINRISK '92 Hemostasis study Arterioscler Thromb Vasc Biol 22 2002 353 358
161. J.M. Edelberg, P.D. Christie, R.D. Rosenberg Regulation of vascular bed-specific prothrombotic potential Circ Res 89 2001 117 124
162. T.S. Edgington So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control Am J Pathol 159 2001 795 796
163. G. Dangas, J.J. Badimon, D.A. Smith Pravastatin therapy in hyperlipidemia effects on thrombus formation and the systemic hemostatic profile J Am Coll Cardiol 33 1999 1294 1304
164. U. Rauch, J.I. Osende, J.H. Chesebro Statins and cardiovascular diseases the multiple effects of lipid-lowering therapy by statins Atherosclerosis 153 2000 181 189
165. L. Badimon, J. Martinez-Gonzalez, T. Royo, R. Lassila, J.J. Badimon A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall - studies in a porcine model Thromb Haemost 82 1999 1736 1742
166. G.J. Miller Hemostasis and cardiovascular risk. The British and European experience Arch Pathol Lab Med 116 1992 1318 1321
167. J.E. Muller, P.G. Kaufmann, R.V. Luepker, M.L. Weisfeldt, P.C. Deedwania, J.T. Willerson Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants Circulation 96 1997 3233 3239
168. J.B. Meigs, M.A. Mittleman, D.M. Nathan Hyperinsulinemia, hyperglycemia, and impaired hemostasis the Framingham Offspring Study JAMA 283 2000 221 228
169. U. Rauch, D. Ziegler, R. Piolot Platelet activation in diabetic cardiovascular autonomic neuropathy Diabet Med 16 1999 848 852
170. A. Sambola, J. Osende, J. Hathcock Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity Circulation 107 2003 973 977
171. J.I. Osende, J.J. Badimon, V. Fuster Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control J Am Coll Cardiol 38 2001 1307 1312
172. D. Tschoepe, U. Rauch, B. Schwippert Platelet-leukocyte-cross-talk in diabetes mellitus Horm Metab Res 29 1997 631 635
173. U. Rauch, J. Crandall, J.I. Osende Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2 Am J Cardiol 86 2000 246 249
174. J. Kallen, K. Welzenbach, P. Ramage Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain J Mol Biol 292 1999 1 9
175. P.S. Frenette Locking a leukocyte integrin with statins N Engl J Med 345 2001 1419 1421
176. D.H. Walter, K. Rittig, F.H. Bahlmann Statin therapy accelerates reendothelialization a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells Circulation 105 2002 3017 3024
177. H. Soejima, H. Ogawa, H. Yasue Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina Circulation 99 1999 2908 2913
178. S. Gando, S. Nanzaki, S. Sasaki, O. Kemmotsu Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation Thromb Haemost 79 1998 1111 1115
179. R.D. Rosenberg, W.C. Aird Vascular bed-specific hemostasis and hypercoagulable states N Engl J Med 340 1999 1555 1564
180. H. Soejima, H. Ogawa, H. Yasue Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction J Am Coll Cardiol 34 1999 983 988
181. Y. Saito, H. Wada, M. Yamamuro Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease Am J Hematol 61 1999 238 242
182. B. Hugel, G. Socie, T. Vu Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia Blood 93 1999 3451 3456
183. P.L. Giesen, U. Rauch, B. Bohrmann Blood-borne tissue factor another view of thrombosis Proc Natl Acad Sci U S A 96 1999 2311 2315
184. J.C. Lewis, A.L. Bennett-Cain, C.S. DeMars Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface Am J Pathol 147 1995 1029 1040
185. R.S. Munford Statins and the acute-phase response N Engl J Med 344 2001 2016 2018
186. G.J. Blake, P.M. Ridker Novel clinical markers of vascular wall inflammation Circ Res 89 2001 763 771
187. P.M. Ridker, N. Rifai, M. Clearfield Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965
188. C. Bickel, H.J. Rupprecht, S. Blankenberg Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease Am J Cardiol 89 2002 901 908
189. A.P. Burke, R.P. Tracy, F. Kolodgie Elevated C-reactive protein values and atherosclerosis in sudden coronary death association with different pathologies Circulation 105 2002 2019 2023
190. T.P. Zwaka, V. Hombach, J. Torzewski C-reactive protein-mediated low density lipoprotein uptake by macrophages implications for atherosclerosis Circulation 103 2001 1194 1197
191. M. Torzewski, C. Rist, R.F. Mortensen C-reactive protein in the arterial intima role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis Arterioscler Thromb Vasc Biol 20 2000 2094 2099
192. V. Pasceri, J.T. Willerson, E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
193. U. Schonbeck, P. Libby CD40 signaling and plaque instability Circ Res 89 2001 1092 1103
194. U. Schonbeck, N. Varo, P. Libby, J. Buring, P.M. Ridker Soluble CD40L and cardiovascular risk in women Circulation 104 2001 2266 2268
195. S. Glagov, C. Zarins, D.P. Giddens, D.N. Ku Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries Arch Pathol Lab Med 112 1988 1018 1031
196. J.F. Toussaint, G.M. LaMuraglia, J.F. Southern, V. Fuster, H.L. Kantor Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo Circulation 94 1996 932 938
197. S. Carr, A. Farb, W.H. Pearce, R. Virmani, J.S. Yao Atherosclerotic plaque rupture in symptomatic carotid artery stenosis J Vasc Surg 23 1996 755 765
198. R. Virmani, J. Narula, A. Farb When neoangiogenesis ricochets Am Heart J 136 1998 937 939
199. C. Yuan, L.M. Mitsumori, M.S. Ferguson In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques Circulation 104 2001 2051 2056
200. C. Yuan, S.H. Zhang, N.L. Polissar Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke Circulation 105 2002 181 185
201. J. Milei, J.C. Parodi, G.F. Alonso, A. Barone, D. Grana, L. Matturri Carotid rupture and intraplaque hemorrhage immunophenotype and role of cells involved Am Heart J 136 1998 1096 1105
202. L.G. Spagnoli, A. Mauriello, G. Sangiorgi Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke JAMA 292 2004 1845 1852
203. K. Ouriel Peripheral arterial disease Lancet 358 2001 1257 1264
204. M.R. Jackson, G.P. Clagett Antithrombotic therapy in peripheral arterial occlusive disease Chest 119 2001 283S 299S
205. F.A. Schmieder, A.J. Comerota Intermittent claudication magnitude of the problem, patient evaluation, and therapeutic strategies Am J Cardiol 87 2001 3 13D
206. R.S. Dieter, W.W. Chu, J.P. Pacanowski Jr., P.E. McBride, T.E. Tanke The significance of lower extremity peripheral arterial disease Clin Cardiol 25 2002 3 10
207. D.P. Faxon, V. Fuster, P. Libby Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology Circulation 109 2004 2617 2625